Literature DB >> 21915759

Medication management during pregnancy: role of the pharmacist.

Nardin Samuel, Adrienne Einarson.   

Abstract

A community pharmacist is frequently the first healthcare professional who is asked to give advice regarding medication use during pregnancy. As 50% of pregnancies are unplanned, a woman often discovers she is pregnant while already taking a medication and visits a pharmacy which is easily accessible, to enquire if she has harmed her baby by this action. Following a review of the literature, of which there is a paucity on this topic, we found that pharmacists often do not feel equipped to dispense teratology information and frequently refer the woman to her attending physician, without giving any information. In addition, it was clear that even when they did give information, it was not necessarily evidence-based and at times, inaccurate and based on their own opinions. In this article, we have attempted to make pharmacists aware of all the sources that are available, to enable them to perform this important role as a member of the health care team. These include websites, texts, evidence-based literature, teratogen information services and more. With the knowledge extracted from various resources, following critical appraisal of the data, they should be more comfortable and feel better equipped to transfer this information to a pregnant woman. In conclusion, while there may be a lack of adequate information regarding use of certain medications during pregnancy, pharmacists should be able to integrate available information with their medication expertise, to make appropriate individual risk/benefit decisions. This requires active engagement with pregnant women, rather than automatically referring them to their physician, thus establishing the pharmacist role as an essential member of the health care team.

Entities:  

Mesh:

Year:  2011        PMID: 21915759     DOI: 10.1007/s11096-011-9560-8

Source DB:  PubMed          Journal:  Int J Clin Pharm


  15 in total

1.  Nitrofurantoin and congenital abnormalities.

Authors:  A E Czeizel; M Rockenbauer; H T Sørensen; J Olsen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-03       Impact factor: 2.435

2.  Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries.

Authors:  D A Lyszkiewicz; S Gerichhausen; I Björnsdóttir; T R Einarson; G Koren; A Einarson
Journal:  Pharm World Sci       Date:  2001-04

3.  Antidepressants and pregnancy: complexities of producing evidence-based information.

Authors:  Adrienne Einarson
Journal:  CMAJ       Date:  2010-05-31       Impact factor: 8.262

4.  The future role of pharmacists in primary care.

Authors:  C P Bradley
Journal:  Br J Gen Pract       Date:  2009-12       Impact factor: 5.386

5.  Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.

Authors:  Lawrence B Finer; Stanley K Henshaw
Journal:  Perspect Sex Reprod Health       Date:  2006-06

6.  [Evaluation of the quality of counseling provided by community pharmacists to pregnant women].

Authors:  Delphine Vanham; Anne Spinewine
Journal:  J Pharm Belg       Date:  2010-09

7.  Drug counselling in pregnancy: an opinion survey of French community pharmacists.

Authors:  Christine Damase-Michel; Céline Vié; Isabelle Lacroix; Maryse Lapeyre-Mestre; J L Montastruc
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-10       Impact factor: 2.890

Review 8.  Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.

Authors:  Janneke Jentink; Helen Dolk; Maria A Loane; Joan K Morris; Diana Wellesley; Ester Garne; Lolkje de Jong-van den Berg
Journal:  BMJ       Date:  2010-12-02

9.  What do pregnant women know about non-steroidal anti-inflammatory drugs?

Authors:  Christine Damase-Michel; Julie Christaud; Alain Berrebi; Isabelle Lacroix; Jean-Louis Montastruc
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-11       Impact factor: 2.890

10.  FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use.

Authors:  Karen B Feibus
Journal:  J Med Toxicol       Date:  2008-12
View more
  6 in total

1.  Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists.

Authors:  Molly M Lynch; Jacqueline B Amoozegar; Emily M McClure; Linda B Squiers; Cheryl S Broussard; Jennifer N Lind; Kara N Polen; Meghan T Frey; Suzanne M Gilboa; Janis Biermann
Journal:  Qual Health Res       Date:  2017-10-03

2.  Women's beliefs about medication use during their pregnancy: a UK perspective.

Authors:  M J Twigg; A Lupattelli; H Nordeng
Journal:  Int J Clin Pharm       Date:  2016-05-30

3.  Self-Medication Among Pregnant Women: Prevalence and Associated Factors.

Authors:  Gabriela Pereira; Fernanda Garanhani Surita; Amanda Canato Ferracini; Cinthia de Souza Madeira; Letícia Silva Oliveira; Priscila Gava Mazzola
Journal:  Front Pharmacol       Date:  2021-09-06       Impact factor: 5.810

4.  "Now what?!" A practice tool for pharmacist-driven options counselling for unintended pregnancy.

Authors:  Nevena Rebić; Kristen Gilbert; Judith A Soon
Journal:  Can Pharm J (Ott)       Date:  2021-07-13

5.  Medications and pregnancy: The role of community pharmacists - A descriptive study.

Authors:  Hoi Ying Leung; Bandana Saini; Helen E Ritchie
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

6.  An exploratory survey on community pharmacists' service provision for pregnant and lactating women in Sharjah, United Arab Emirates.

Authors:  Zahraa Abdullatif Akkad; Muaed Alomar; Subish Palaian
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.